Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine Impact on Endothelial Function
NCT00564824Phase 3Completed
- Sponsor
- Sheba Medical Center
- Start
- Nov 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of caffeine in ischemic heart disease (IHD), sponsored by Sheba Medical Center. Started Nov 2007; status: completed.
02
Drugs
caffeine
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT00564824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564824.